Financial Snapshot

Revenue
$15.31M
TTM
Gross Margin
3.82%
TTM
Net Earnings
-$6.980M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
107.03%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
$3.268M
Q3 2024
Cash
Q3 2024
P/E
-2.851
Nov 29, 2024 EST
Free Cash Flow
-$2.316M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Revenue $19.35M $4.832M $0.00 $0.00 $0.00 $0.00 $102.4K $163.4K $250.0K $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change 300.36% -100.0% -37.3% -34.66%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Revenue $19.35M $4.832M $0.00 $0.00 $0.00 $0.00 $102.4K $163.4K $250.0K $0.00 $0.00 $0.00 $0.00 $0.00
Cost Of Revenue $13.11M $3.439M $77.94K $77.94K $108.3K $150.0K $120.0K
Gross Profit $6.235M $1.393M $24.48K $24.48K $55.10K $100.0K $120.0K
Gross Profit Margin 32.23% 28.83% 23.9% 33.73% 40.0%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Selling, General & Admin $4.022M $2.023M $1.414M $1.929M $2.683M $2.824M $2.523M $2.633M $2.230M $2.800M $3.020M $2.290M $1.260M $30.00K
YoY Change 98.8% 43.08% -26.72% -28.09% -5.0% 11.91% -4.15% 18.06% -20.36% -7.28% 31.88% 81.75% 4100.0%
% of Gross Profit 64.5% 145.19% 11535.54% 10308.05% 4778.04% 2230.0% 2333.33%
Research & Development $458.9K $470.8K $298.9K $408.9K $1.010M $1.743M $1.898M $894.0K $610.0K $575.1K $736.4K $250.0K
YoY Change -2.53% 57.5% -26.9% -59.51% -42.06% -8.16% 112.29% 46.55% 6.07% -21.91% 194.57%
% of Gross Profit 7.36% 33.79% 7119.77% 7752.53% 1622.43% 610.0% 479.24%
Depreciation & Amortization $1.782M $395.5K $0.00 $0.00 $0.00 $12.27K
YoY Change 350.41% -100.0%
% of Gross Profit 28.57% 28.39% 50.12%
Operating Expenses $4.480M $2.494M $1.713M $2.338M $3.693M $4.567M $4.421M $3.527M $2.840M $575.1K $736.4K $2.550M $1.260M $30.00K
YoY Change 79.67% 45.6% -26.75% -36.68% -19.14% 3.29% 25.37% 24.18% 393.83% -21.91% -71.12% 102.38% 4100.0%
Operating Profit $1.754M -$1.100M -$4.542M -$4.397M -$3.472M -$2.740M -$3.598M -$2.549M
YoY Change -259.42% 3.31% 26.65% 26.7% -23.84% 41.14%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Interest Expense $505.9K $81.18K $0.00 $36.96K $117.3K $87.75K -$1.748M $2.600M $404.3K $346.9K -$220.0K -$20.00K $0.00
YoY Change 523.22% -100.0% -68.5% 33.71% -105.02% -167.22% 543.06% 16.55% -257.69% 1000.0%
% of Operating Profit 28.84%
Other Income/Expense, Net $1.377M $28.26K -$270.00 $790.00 $23.52K $0.00 $0.00 -$80.00K
YoY Change 4772.04% -10565.56% -134.18% -96.64% -100.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Pretax Income $3.131M -$1.072M -$1.713M -$880.9K -$3.632M -$4.449M -$4.309M -$5.219M -$140.0K -$4.050M -$4.150M -$2.740M -$1.320M -$40.00K
YoY Change -392.03% -37.41% 94.47% -75.75% -18.37% 3.26% -17.44% 3628.13% -96.54% -2.41% 51.46% 107.58% 3200.0%
Income Tax $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings $3.131M -$1.072M -$1.713M -$880.9K -$4.365M -$20.14M -$4.309M -$5.219M -$140.0K -$4.153M -$2.743M -$2.740M -$1.320M -$40.00K
YoY Change -392.03% -37.41% 94.47% -79.82% -78.32% 367.31% -17.44% 3628.13% -96.63% 51.42% 0.09% 107.58% 3200.0%
Net Earnings / Revenue 16.18% -22.19% -4207.19% -3195.02% -56.0%
Basic Earnings Per Share $0.04 -$0.02
Diluted Earnings Per Share $0.04 -$0.02 -$33.61K -$17.33K -$84.70K -$610.2K -$186.4K -$384.0K -$0.02 -$0.57 -$0.69 -$0.51 -$0.26 -$0.01

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Cash & Short-Term Investments $2.177M $442.4K $38.34K $884.1K $2.392M $5.983M $656.3K $1.153M $100.0K $390.0K $1.400M $390.0K $530.0K $10.00K
YoY Change 392.08% 1053.81% -95.66% -63.04% -60.01% 811.6% -43.07% 1052.77% -74.36% -72.14% 258.97% -26.42% 5200.0%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $115.3K $880.00 $3.880K $3.200K $15.67K $50.55K $5.660K $3.060K $0.00 $0.00 $20.00K $130.0K $0.00 $0.00
YoY Change 13004.55% -77.32% 21.25% -79.58% -69.0% 793.11% 84.97% -100.0% -84.62%
Inventory $0.00 $10.00K $10.00K
Prepaid Expenses
Receivables $7.433M $981.4K $19.36K $13.84K $19.20K $30.00K $60.00K
Other Receivables $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $9.725M $1.425M $42.23K $887.3K $2.408M $6.053M $675.8K $1.175M $130.0K $460.0K $1.420M $530.0K $530.0K $10.00K
YoY Change 582.62% 3273.53% -95.24% -63.15% -60.22% 795.64% -42.49% 803.86% -71.74% -67.61% 167.92% 0.0% 5200.0%
Property, Plant & Equipment $13.30M $6.046M $0.00 $123.6K
YoY Change 120.03% -100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $9.980K $8.890K $8.690K $9.500K $35.75K $22.66K $0.00 $10.00K
YoY Change 12.26% 2.3% -8.53% -73.43% 57.77% -100.0%
Total Long-Term Assets $14.06M $6.806M $8.690K $9.500K $159.4K $22.66K $0.00 $0.00 $0.00 $0.00 $0.00 $10.00K $0.00 $0.00
YoY Change 106.64% 78217.95% -8.53% -94.04% 603.27% -100.0%
Total Assets $23.79M $8.230M $50.92K $896.8K $2.567M $6.075M $675.8K $1.175M $130.0K $460.0K $1.420M $540.0K $530.0K $10.00K
YoY Change
Accounts Payable $3.714M $233.8K $82.56K $33.44K $0.00 $5.200K $200.5K $373.7K $240.0K $130.0K $80.00K $110.0K $80.00K $10.00K
YoY Change 1488.47% 183.2% 146.89% -100.0% -97.41% -46.35% 55.71% 84.62% 62.5% -27.27% 37.5% 700.0%
Accrued Expenses $101.3K $0.00 $125.7K $0.00 $151.7K $0.00 $10.00K $20.00K $10.00K
YoY Change -100.0% -100.0% -100.0% -50.0% 100.0%
Deferred Revenue
YoY Change
Short-Term Debt $2.400M $0.00 $350.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $200.0K $80.00K
YoY Change -100.0% -100.0% 150.0%
Long-Term Debt Due $2.756M $1.319M
YoY Change 108.9%
Total Short-Term Liabilities $8.971M $1.553M $432.6K $33.44K $1.285M $1.054M $353.5K $800.7K $650.0K $1.540M $1.530M $530.0K $310.0K $100.0K
YoY Change 477.66% 259.03% 1193.54% -97.4% 21.88% 198.21% -55.85% 23.18% -57.79% 0.65% 188.68% 70.97% 210.0%
Long-Term Debt $5.250M $3.738M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $580.0K $280.0K $0.00
YoY Change 40.45% -100.0% 107.14%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $5.250M $3.738M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $580.0K $280.0K $0.00
YoY Change 40.45% -100.0% 107.14%
Total Liabilities $14.22M $5.291M $432.6K $33.44K $1.285M $1.054M $353.5K $800.7K $650.0K $1.540M $1.530M $1.110M $580.0K $100.0K
YoY Change 168.78% 1123.19% 1193.54% -97.4% 21.88% 198.21% -55.85% 23.18% -57.79% 0.65% 37.84% 91.38% 480.0%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Basic Shares Outstanding 83.13M shares 68.11M shares
Diluted Shares Outstanding 83.13M shares 68.11M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $19.898 Million

About RANGE IMPACT, INC.

Range Impact, Inc. engages in unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders. The company is headquartered in Cleveland, Ohio and currently employs 24 full-time employees. The company went IPO on 2012-03-01. The firm owns and operates several complementary operating businesses focused on developing long-term solutions to environmental, social, and health challenges. Its segments include Range Reclaim; Range Minerals; Range Water; Range Security, and Range Land. Range Reclaim segment provides land reclamation, water restoration and environmental consulting services to mining and non-mining customers throughout the Appalachian region. The Range Minerals segment provides subcontracted mining and reclamation activities. The Range Water segment is involved in biochar product development and water solutions business. The Range Security is focused on providing eco-friendly, technology-driven security services to active and former mine sites. Range Land segment is focused on mine land being acquired, reclaimed and repurposed for non-fossil fuel uses.

Industry: Heavy Construction Other Than Bldg Const - Contractors Peers: CLS Holdings USA, Inc. Emmaus Life Sciences, Inc. AmeriCann, Inc. ARTELO BIOSCIENCES, INC. CNS Pharmaceuticals, Inc. GB SCIENCES INC JOHNSON & JOHNSON PALISADE BIO, INC.